BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1259447)

  • 1. Clofazimine. A new agent for the treatment of pyoderma gangrenosum.
    Michaëlsson G; Molin L; Ohmann S; Gip L; Lindström B; Skogh M; Trolin I
    Arch Dermatol; 1976 Mar; 112(3):344-9. PubMed ID: 1259447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pyoderma gangrenosum: Clofazimine therapy].
    Beurey J; Weber M; Delrous JL; Chaulieu Y
    Ann Dermatol Venereol; 1977 Oct; 104(10):631-4. PubMed ID: 610518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pyoderma gangrenosum with clofazimine. A case report and review of associated diseases.
    Lovett GW; Field JP; King LE
    J Tenn Med Assoc; 1981 Aug; 74(8):567-8. PubMed ID: 7265955
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyoderma gangrenosum treated with clofazimine: clinical evaluation of 7 cases.
    Rasmussen I
    Acta Derm Venereol; 1983; 63(6):552-3. PubMed ID: 6198851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofazimine in the treatment of pyoderma gangrenosum.
    Thomsen K; Rothenborg HW
    Arch Dermatol; 1979 Jul; 115(7):851-2. PubMed ID: 453894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofazimine in dermatitis ulcerosa (pyoderma gangrenosum). Open clinical trial.
    Mensing H
    Dermatologica; 1988; 177(4):232-6. PubMed ID: 3066646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pyoderma gangrenosum: 2 cases treated with lamprene. Immunologic study].
    De Maubeuge J; Ledoux M; Duchateau J; Schell E; Achten G
    LARC Med; 1982 Mar; 2(3):244-7. PubMed ID: 6984873
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pyoderma gangrenosum treated with prednisolone and clofazimine].
    Ohela K
    Duodecim; 1981; 97(19):1633-5. PubMed ID: 7343289
    [No Abstract]   [Full Text] [Related]  

  • 9. Pyoderma gangrenosum associated with regional enteritis. Improvement in defective granulocyte function and healing of skin lesions during administration of clofazimine.
    Brandt L; Gärtner I; Nilsson PG; Olofsson T
    Acta Med Scand; 1977 Jan; 201(1-2):141-4. PubMed ID: 835365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pyoderma gangrenosum with cyclosporine.
    Matis WL; Ellis CN; Griffiths CE; Lazarus GS
    Arch Dermatol; 1992 Aug; 128(8):1060-4. PubMed ID: 1497359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pyoderma gangrenosum associated with seronegative polyarthritis. Report of a case. Review of the literature (author's transl)].
    Claudy AL; Gogue Y; Volle H
    Ann Dermatol Venereol; 1978; 105(8-9):701-4. PubMed ID: 736438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pyoderma gangrenosum: 2 cases with perineal localization].
    Cola B; Porzio F; Farella S
    Ann Ital Chir; 1980; 52(4):465-75. PubMed ID: 7224433
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lamprène. New therapeutic indications (excluding leprosy)].
    Beurey J; Weber M; Chaulieu Y
    LARC Med; 1982 Jan; 2(1):48-50, 53, 55. PubMed ID: 6219260
    [No Abstract]   [Full Text] [Related]  

  • 14. Splenic infarction and tissue accumulation of crystals associated with the use of clofazimine (Lamprene; B663) in the treatment of pyoderma gangrenosum.
    McDougall AC; Horsfall WR; Hede JE; Chaplin AJ
    Br J Dermatol; 1980 Feb; 102(2):227-30. PubMed ID: 7387877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyoderma gangrenosum treated with clofazimine. Report of three cases.
    Kark EC; Davis BR; Pomeranz JR
    J Am Acad Dermatol; 1981 Feb; 4(2):152-9. PubMed ID: 7217385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orange/black discolouration of the bowel (at laparotomy) due to clofazimine.
    Merrett MN; King RW; Farrell KE; Zeimer H; Guli E
    Aust N Z J Surg; 1990 Aug; 60(8):638-9. PubMed ID: 2390049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dermatitis ulcerosa or superficial granulomatous pyoderma. Functional abnormalities of the neutrophils and transient efficacy of clofazimine].
    Grob JJ; Mège JL; Collet-Villette AM; Bonerandi JJ
    Ann Dermatol Venereol; 1989; 116(11):829-31. PubMed ID: 2619178
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyoderma gangrenosum associated with selective hereditary IgA deficiency.
    Bundino S; Zina AM
    Dermatologica; 1984; 168(5):230-2. PubMed ID: 6724079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lamprene in ano-perineal lesions of Crohn's disease. A retrospective study].
    Pinès AE; Cosnes J; Carbonnel F; Ngo Y; Beaugerie L; Gendre JP; Le Quintrec Y
    Ann Gastroenterol Hepatol (Paris); 1993; 29(4):155-63. PubMed ID: 8239487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of lamprène in dermatology].
    Chavaz P; Laugier P
    LARC Med; 1982 Jan; 2(1):56-7. PubMed ID: 7162254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.